Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 255 publications
Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry
Journal: Se pu = Chinese journal of chromatography
Published: September 24, 2025
Canine Mdr1 Knockout MDCK Cells Reliably Estimate Human Small Intestinal Permeability (Peff) and Fraction Absorbed (fa).
Journal: Molecular pharmaceutics
Published: September 07, 2025
Discovery of Highly Selective and Potent Macrocyclic JAK2 Inhibitors for the Treatment of MPNs.
Journal: Journal of medicinal chemistry
Published: August 06, 2025
Cutaneous Extramedullary Hematopoiesis in a Patient With Myelofibrosis.
Journal: American journal of hematology
Published: July 13, 2025
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for hepatocellular carcinoma, fedratinib for myelofibrosis, talquetamab for multiple myeloma, and belzutifan for tumors associated with von Hippel-Lindau disease and renal cell carcinoma.
Journal: International journal of clinical oncology
Published: July 11, 2025
Validated green ultra-fast UPLC-MS/MS method for the quantification of fedratinib in an HLM matrix: application to in vitro and in silico metabolic stability studies.
Journal: Analytical methods : advancing methods and applications
Published: July 01, 2025
Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis With a Focus on Anemia Outcomes.
Journal: Journal of hematology
Published: June 25, 2025
Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosis.
Journal: Future oncology (London, England)
Published: June 06, 2025
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Fat Fraction MRI for Longitudinal Assessment of Bone Marrow Heterogeneity in a Mouse Model of Myelofibrosis.
Journal: Tomography (Ann Arbor, Mich.)
Published: May 29, 2025
Fedratinib inhibits ovarian cancer progression by downregulating QPCT expression.
Journal: Discover oncology
Published: April 30, 2025
1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of drug-drug interaction with moderate CYP3A inhibitor.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: April 03, 2025
Last Updated: 10/31/2025